Zobrazeno 1 - 10
of 44
pro vyhledávání: '"William P. Baldus"'
Publikováno v:
Gastroenterology. 112:882-888
BACKGROUND & AIMS: Hemosiderosis may have a detrimental effect on some chronic liver diseases. The aim of this study was to determine the prevalence and diagnostic implications of hemosiderosis in cirrhosis. METHODS: Tissue iron in 447 cirrhotic live
Autor:
Russell H. Wiesner, E.Rolland Dickson, Steven S. Rossi, Alan F. Hofmann, Monte L. Anderson, Keith D. Lindor, Roberta A. Jorgensen, William P. Baldus, Gregory J. Gores, Stephen Lange
Publikováno v:
Hepatology. 22:1158-1162
Ursodeoxycholic acid (UDCA) and methotrexate (MTX) have both been proposed as treatments for patients with primary biliary cirrhosis (PBC). It has been suggested that a combination of the two drugs may offer advantages over either used separately. In
Autor:
Keith D. Lindor, E. Rolland Dickson, Roberta A. Jorgensen, Monte L. Anderson, Russell H. Wiesner, Gregory J. Gores, Stephen M. Lange, Steven S. Rossi, Alan F. Hofmann, William P. Baldus
Publikováno v:
Hepatology. 22:1158-1162
Publikováno v:
Hepatology. 17:1157-1162
Publikováno v:
Mayo Clinic Proceedings. 68:263-267
The diagnosis of homozygous hemochromatosis (HH) should be based on appropriate findings on liver biopsy specimens. In cases with equivocal morphologic features, quantitative tissue iron determination and calculation of the hepatic iron index general
Autor:
Vijayan Balan, Virginia V. Michels, Mary F. Burritt, Virgil F. Fairbanks, William P. Baldus, George G. Klee
Publikováno v:
Gastroenterology. 107(2)
Current emphasis in hemochromatosis has focused on early detection and treatment to prevent permanent liver damage and hepatocellular carcinoma. Thus far, only normal population and high-risk groups have been screened but not patients seeking medical
Autor:
Roberta A. Jorgensen, Jurgen Ludwig, Keith D. Lindor, William P. Baldus, Paul A. Murtaugh, Alan F. Hofmann, Jay M. Harrison, Steven S. Rossi, Gene LeSage, Stephen Lange, Russell H. Wiesner, Monte L. Anderson, E. Rolland Dickson
Publikováno v:
Gastroenterology. 106(5)
Background/Aims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA. Efficacy was assessed by time to treatment failure
Autor:
Keith D. Lindor, Henry A. Homburger, E. Rolland Dickson, Russell H. Wiesner, Jurgen Ludwig, William P. Baldus, Roberta A. Jorgensen
Publikováno v:
The New England journal of medicine. 322(20)
Primary biliary cirrhosis is a progressive disease of the liver characterized by the immunologic destruction of bile ducts; effective therapy is lacking. We therefore evaluated the safety and efficacy of low-dose cyclosporine in 29 patients with prim
Autor:
Keith D. Lindor, Santiago J. Munoz, E. Rolland Dickson, Jurgen Ludwig, Henry A. Homburger, William P. Baldus, Russell H. Wiesner, Roberta A. Jorgensen
Publikováno v:
New England Journal of Medicine. 323:1352-1353